glioblastoma stem-like cells give rise tumour endothelium 
glioblastoma gbm among aggressive human cancers key feature gbms extensive network abnormal vasculature characterized glomeruloid structures endothelial hyperplasia yet mechanisms angiogenesis origin tumour endothelial cells remain poorly defined- demonstrate subpopulation endothelial cells within glioblastomas harbour somatic mutations identified within tumour cells amplification egfr chromosome additionally demonstrate stem-cell-like cd133+ fraction includes subset vascular endothelial-cadherin cd144-expressing cells show characteristics endothelial progenitors capable maturation endothelial cells extensive vitro vivo lineage analyses including single cell clonal studies show subpopulation cd133+ stem-like cell fraction multipotent capable differentiation along tumour endothelial lineages possibly via intermediate cd133+/cd144+ progenitor cell findings supported genetic studies specific exons selected cancer genome atlas quantitative fish comparative genomic hybridization data demonstrate identical genomic profiles cd133+ tumour cells endothelial progenitor derivatives mature endothelium exposure clinical anti-angiogenesis agent bevacizumab gamma-secretase inhibitor well knockdown shrna studies demonstrate blocking vegf silencing vegfr2 inhibits maturation tumour endothelial progenitors endothelium differentiation cd133+ cells endothelial progenitors whereas c-secretase inhibition notch1 silencing blocks transition endothelial progenitors data may provide new perspectives mechanisms failure anti-angiogenesis inhibitors currently use lineage plasticity capacity generate tumour vasculature putative cancer stem cells within glioblastoma novel findings provide new insight biology gliomas definition cancer stemness well mechanisms tumour neo-angiogenesis 
